Back to Federated Hermes, Inc. Federated Hermes, Inc.

ANRO

Showing 8 of 10 quarters

Position history for Federated Hermes, Inc.Federated Hermes, Inc.'s holdings in Alto Neuroscience, Inc.

No. Federated Hermes exited its ANRO (Alto Neuroscience) position in Q3 2026. Its Q2 2026 13F listed 110 shares worth $2,903. Federated Hermes already held ANRO in its Q1 2024 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$183,040

Total Shares Change

-16,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%$25.53
0
2026-Q2
Decreased
110
-83.2%
$2,9030.0%$26.39
0
2026-Q1
Decreased
654
-15.1%
$14,7020.0%$22.48
0
2025-Q4
Decreased
770
-77.0%
$13,7060.0%$17.80
0
2025-Q3
Increased
3,347
+337.5%
$13,4550.0%$4.02
20
2025-Q2
New
765
-
$1,6830.0%$2.20
17
2024-Q4
Exited
0
-100.0%
$00.0%$4.23
0
2024-Q3
Increased
16,000
+33.3%
$183,0400.0%$11.44
29

Other major holders of ANRO: BlackRock, Inc., Adage Capital Partners GP, L.L.C., Vanguard Capital Management LLC, FMR LLC, Point72 Asset Management, L.P.

Optional analytics helps us improve. How it’s used